Depressed Patients for Depression

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
San Francisco Veterans Affairs Medical Center, San Francisco, CADepressionNIRSIT - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test a new protocol using Near Infrared Spectroscopy to diagnose and measure the severity of Major Depressive Disorder.

Eligible Conditions
  • Depression

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Ketamine
1
Interpersonal psychotherapy for major depression following perinatal loss
1
CYB003

Study Objectives

6 Primary · 3 Secondary · Reporting Duration: Each measurement is over 10 to 15 mins long, taken during the performance of VFT and CHR, on the day of initiation of treatment for MDD, but before the treatment is given.

Week 6
Beck's Depression Inventory - II (BDI-II) Scores
Week 3
Change in Frontal Deoxyhemoglobin concentration 3 weeks after initiation of treatment for MDD
Change in Frontal Oxyhemoglobin concentration 3 weeks after initiation of treatment for MDD
Week 6
Change in Frontal Deoxyhemoglobin concentration 6 weeks after initiation of treatment for MDD
Change in Frontal Oxyhemoglobin concentration 6 weeks after initiation of treatment for MDD
Each measurement is over 10 to 15 mins long, taken during the performance of VFT and CHR, on the day of initiation of treatment for MDD, but before the treatment is given.
Change in Frontal Deoxyhemoglobin concentration before initiation of treatment for MDD
Change in Frontal Oxyhemoglobin concentration before initiation of treatment for MDD
Week 6
Hamilton Depression Rating Scale (HAM-D) Score
Week 6
Patient Health Questionnaire-9 (PHQ-9) Scores

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
Ketamine
2
Interpersonal psychotherapy for major depression following perinatal loss
1
CYB003

Trial Design

1 Treatment Group

Depressed Patients
1 of 1

Active Control

90 Total Participants · 1 Treatment Group

Primary Treatment: Depressed Patients · No Placebo Group · N/A

Depressed Patients
Device
ActiveComparator Group · 1 Intervention: NIRSIT · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: each measurement is over 10 to 15 mins long, taken during the performance of vft and chr, on the day of initiation of treatment for mdd, but before the treatment is given.

Who is running the clinical trial?

Obelab Inc.UNKNOWN
University of California, San FranciscoLead Sponsor
2,312 Previous Clinical Trials
11,758,236 Total Patients Enrolled
63 Trials studying Depression
19,817 Patients Enrolled for Depression
San Francisco Veterans Affairs Medical CenterFED
45 Previous Clinical Trials
9,568 Total Patients Enrolled
3 Trials studying Depression
553 Patients Enrolled for Depression
Arthur Wallace, MD, PhDPrincipal InvestigatorSan Francisco Veterans Affairs Medical Center
2 Previous Clinical Trials
139 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Frequently Asked Questions

Are there still vacancies available for participants in this research project?

"According to the data posted on clinicaltrials.gov, this medical study is not actively looking for participants at present. The trial was initially launched on April 1st 2019 and has been edited as recently as August 10th 2020. Though no longer recruiting patients, 1317 other trials are currently in need of volunteers." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top